Glucose Monitoring Device Market to 2019
Published Date: February 2014 Price: Single User: US$3500
No. of Pages: 90 Corporate User: US$10500
New Market Research Report on “ Glucose Monitoring Device Market to 2019� added to ReportsnReports.com
The UK is among one of the fattest countries in the EU. In 2010 an estimated 63% of people aged 16 or over in England and 57% in Wales were classified as overweight or obese. In Scotland 63.3% of adults aged 16 to 64 were in that category. While the proportion of overweight people has not changed significantly, the proportion of obese people has increased by 11 percentage points since 1993. Overweight and obesity are steadily spreading in both the adult
Glucose Monitoring Device Market to 2019 and the child populations across the UK. The available data and reports on obesity in the UK paint quite a worrying picture of the progression of the obesity epidemic in the UK population over the coming decades. As the WHO warns of the many impacts of a global obesity epidemic, the UK is faced with difficult choices to tackle its own obesity problem and avert a future where 60% of men and 50% of women are obese. Browse more research reports on Medical Devices @ http://www.reportsnreports.com/market-research/medical-devices/ .
Glucose Monitoring Device Market to 2019 The direct and indirect costs of obesity are high. Across the UK, the estimated direct costs to the NHS of treating overweight and obesity as well as obesity-related illnesses jumped from £479.3m in 1998 to £4.2bn in 2007. The estimated indirect costs of obesity to the UK economy were valued at anywhere between £2.6bn and £15.8bn per year in 2007. The NHS now spends an estimated £50m to £85m per year on bariatric surgery. NHS-funded bariatric procedures in England jumped from 261 in 2000/01 to 8,087 in 2010/11 while 10,831,705 prescription items for drugs for the treatment of obesity were Buy a copy of this report @ http://www.reportsnreports.com/purchase.aspx?name=274855 .
Glucose Monitoring Device Market to 2019 dispensed in England alone between 1999 and 2011, amounting to nearly ÂŁ420.5m. Surgical and pharmaceutical interventions are now restricted by artificial caps put on referrals and the lack of choice of prescription obesity drugs available apart from Orlistat. However, costs overall will increase as the proportion of obese people increases.
For Complete Detail Follow Below Link:
Complete Report @ http://www.reportsnreports.com/reports/274855-glucose-monitoring-device-market-to-2019-techno .
About ReportsnReports ReportsnReports.com is your single source for all market research needs. Our database includes 250,000+ syndicated market research reports from 100+ leading global publishers covering indepth analysis of over 5000 micro markets. With comprehensive information about the publishers and their report methodology, data sources, etc. we help you in your purchase decision by mapping your information needs with the most relevant available reports in our library.
Connect with us: sales@reportsandreports.com + 1 888 391 5441
Contact: sales@reportsandreports.com for further information. Contact: sales@reportsandreports.com for further information.